New therapies in Hodgkin's lymphoma

Clin Adv Hematol Oncol. 2004 Feb;2(2):80, 83.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Disease Management
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / mortality
  • Hodgkin Disease / pathology
  • Hodgkin Disease / radiotherapy
  • Hodgkin Disease / therapy*
  • Humans
  • Immunotherapy
  • Neoplasm Staging
  • Neoplasms, Second Primary / chemically induced
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Salvage Therapy / methods

Substances

  • Antibodies, Monoclonal